A Study of Atlacabtagene Autoleucel CAR T-cells for Adults With Relapsed Large B-cell Lymphoma

Clinical trial NCT06486051 · RECRUITING

Trial details

NCT number: NCT06486051
Sponsor: Malaghan Institute of Medical Research
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Large B-cell Lymphoma Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Primary Mediastinal Large B-cell Lymphoma (PMBCL)Transformed Non-Hodgkin Lymphoma

Start date: 2024-07-12
Primary completion: 2027-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.